Source: Health Products Regulatory Authority (ZA) Revision Year: 2020 Publisher: sanofi-aventis south africa (pty) ltd, 2 Bond Street, Midrand, 1685, South Africa
IMOVANE TABLETS.
| Pharmaceutical Form |
|---|
|
White, film-coated, elliptical tablets, with a breakline on one side. |
Each tablet contains: Zopiclone 7,5 mg.
Other excipients are: Calcium hydrogen phosphate, lactose, magnesium stearate, sodium starch glycolate, wheat starch and the film-coating contains: hypromellose, macrogol 6000 and titanium dioxide.
Contains sugar (lactose): IMOVANE contains 31,6 mg lactose per tablet.
| Active Ingredient | Description | |
|---|---|---|
| Zopiclone |
Zopiclone is a hypnotic agent belonging to the cyclopyrrolone class of psychotherapeutic agents. It rapidly initiates and sustains sleep without reduction of total REM sleep and with preservation of slow wave sleep. Negligible residual effects are seen the following morning. Its pharmacological properties include hypnotic, sedative, anxiolytic, anticonvulsant and muscle-relaxant actions. |
| List of Excipients |
|---|
|
Calcium hydrogen phosphate Film-coating contains: Hypromellose |
Blister packs of 30 tablets.
sanofi-aventis south africa (pty) ltd, 2 Bond Street, Midrand, 1685, South Africa
T/2.2/104
Date of registration: 15 July 1988
| Drug | Countries | |
|---|---|---|
| IMOVANE | Australia, Brazil, Canada, Estonia, Finland, France, Hong Kong, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
